Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Novus Acquisition And Development Corp
Novus (OTC: NDEV) Reports 2025 Year-End Financial Results
Business
Mar 3 2026
4 min read

Novus (OTC: NDEV) Reports 2025 Year-End Financial Results

The company achieved a 14.7% increase in earnings while simultaneously safeguarding shareholder value through effective capital structure management.

MIAMI, FL – March 3, 2026 – Novus Acquisition & Development Corp. (OTC: NDEV), the nation's exclusive health insurance provider strategically combining traditional health plans with cannabis integration, today announced its financial results for the fiscal year ended December 31, 2025. The company’s Annual Report reveals consistent revenue expansion, improved liquidity, and a strengthening balance sheet, underscoring the competitive advantage of its resilient, "non-plant-touching" dual-platform model.

Fiscal Year 2025 Financial Highlights:


  • Revenue Expansion: Total revenues grew to $404,888 in 2025, up from $368,687 in 2024, representing a 9.8% year-over-year increase.

  • Increased Profitability: Net Income—which also represents the Company's Adjusted Operating Income increased by 14.7%, rising to $195,236 from $170,256 in the previous fiscal year.

  • Strengthened Balance Sheet: Total assets grew to $1,937,132, driven by continued investments in proprietary software and insurance contracts. Cash and cash equivalents improved to $241,912, a 10.7% increase over 2024.

Strategic and Corporate Highlights:

  • Industry-Exclusive Integration: Novus is the only health insurance carrier in the United States that integrates cannabis coverage directly with traditional health plans, providing a truly comprehensive approach to patient care.

  • Dual Proprietary Platforms: To ensure strict regulatory compliance and operational efficiency, the Company successfully routes its prescription drug plan and its cannabis benefits through two highly advanced, proprietary platforms that are completely separate.

  • Clean Capital Structure: The Company continues to operate with a highly favorable debt-to-equity profile, maintaining zero outstanding or issued convertible notes.

  • Management Conviction: Reflecting strong internal belief in the Company's long-term trajectory, there have been absolutely zero insider management shares sold over the past three years.

  • "Non-Plant-Touching" Resilience: Novus does not cultivate, process, distribute, or sell cannabis. By generating revenue solely from insurance policy receivables, the Company’s business model is completely insulated from supply chain volatility and federal regulatory delays (such as the SAFE Banking Act) that affect traditional operators.

"As the combined medical and recreational cannabis markets approach a projected $47 billion by the end of 2026, Novus is uniquely positioned to bridge the 'Affordability Gap' for consumers," stated Frank Labrozzi, CEO of Novus Acquisition & Development Corp. "We are proud to be the only health insurance carrier that integrates cannabis benefits with standard health plans. By utilizing two proprietary but separate platforms to manage our prescription drug plans and our cannabis benefits, we maintain rigorous compliance while providing a seamless, cost-saving ecosystem for our patients. Because we do not touch the plant, our operations run independently of federal reclassification hurdles, allowing us to thrive safely and compliantly on a state-by-state basis while prioritizing shareholder value."

Through its wholly owned California-based subsidiary, WCIG Insurance Services, Inc., Novus continues to offer comprehensive policies nationwide, including coverage for CBD concentrate, state-specific THC plans, prescription drug plans, dental, vision, hearing, and telemedicine services.

Further Research & Investor Links:

About Novus Acquisition & Development Corp. Novus is a legal cannabis health insurance carrier operating under an HMO-style model. The Company provides risk and non-risk insurance coverage, offering patient members significant discounts of 30% to 45% on their purchases, equating to substantial annual savings.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. The Company assumes no obligation to update these statements except as required by law. This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, statements in this press release that are not statements of historical fact may be considered forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. 

Investor Contact Information

Investor Website

855-228-7355 

Email: [email protected]